Meeting minutes
Oregon Prescription Drug Affordability Board · January 21, 2026
The Oregon Prescription Drug Affordability Board on Jan. 21, 2026, voted to identify four products—Vraylar, Cosentyx, Trulicity and Lantus SoloStar—as potentially creating affordability challenges for Oregon patients and discussed recommendations for its 2025 report to the Legislature.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.